A functional polymorphism rs11614913 in microRNA‑196a2 is associated with an increased risk of colorectal cancer although not with tumor stage and grade

Wang,Na; Li,Yan; Zhu,Ling‑Jun; Zhou,Rong‑Miao; Jin,Wei; Guo,Xiao‑Qing; Wang,Chun‑Mei; Chen,Zhi‑Feng; Liu,Wei

doi:10.3892/br.2013.146

A functional polymorphism rs11614913 in microRNA‑196a2 is associated with an increased risk of colorectal cancer although not with tumor stage and grade

Authors:
- Na Wang
- Yan Li
- Ling‑Jun Zhu
- Rong‑Miao Zhou
- Wei Jin
- Xiao‑Qing Guo
- Chun‑Mei Wang
- Zhi‑Feng Chen
- Wei Liu
View Affiliations

Affiliations: Department of Molecular Biology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China, Department of Oncology, The First Afﬁliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, Department of Neurology, Hebei Provincial People's Hospital, Shijiazhuang, Hebei 050051, P.R. China, Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA, School of Life Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, P.R. China, Department of Cancer Prevention and Control, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China , Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
Published online on: July 22, 2013 https://doi.org/10.3892/br.2013.146
Pages: 737-742

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A C/T polymorphism (rs11614913) was identiﬁed in the microRNA (miRNA) 196a2 (miR-196a2) gene and was implicated in the susceptibility to cancer. Numerous studies have investigated its association with the risk of colorectal cancer (CRC). However, the results were inconsistent and inconclusive. The present meta‑analysis was conducted based on the results of six published case‑control studies comprising 1,754 cases and 2,430 controls (up to November, 2012). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for the allelic and genotypic comparisons following the co‑dominant, dominant and recessive genetic models. The Chi‑square‑based Q‑test was used to assess heterogeneity. Egger's test and inverted funnel plots were used to investigate publication bias. Subgroup analysis was also performed. The results demonstrated that almost all the genetic models (except the model of CT vs. TT) indicated a significant association between rs11614913 polymorphism and CRC risk. The subgroup analysis in an Asian population also demonstrated similar results. However, there was no signiﬁcant association of miR‑196a2 rs11614913 polymorphism with the clinical characteristics of CRC patients. Our results confirmed the association of the polymorphism rs11614913 with the risk of CRC, but not with tumor stage and grade.

View Figures

View References

1	Schnekenburger M and Diederich M: Epigenetics offer new horizons for colorectal cancer prevention. Curr Colorectal Cancer Rep. 8:66–81. 2012. View Article : Google Scholar : PubMed/NCBI
2	Glade MJ: Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 15:523–526. 1999.PubMed/NCBI
3	Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst. 91:916–932. 1999. View Article : Google Scholar : PubMed/NCBI
4	Jasperson KW, Tuohy TM, Neklason DW and Burt RW: Hereditary and familial colon cancer. Gastroenterology. 138:2044–2058. 2010. View Article : Google Scholar : PubMed/NCBI
5	Burt RW: Colon cancer screening. Gastroenterology. 119:837–853. 2000. View Article : Google Scholar
6	Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki K: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 343:78–85. 2000. View Article : Google Scholar
7	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
8	Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar
9	Vasudevan S, Tong Y and Steitz JA: Switching from repression to activation: microRNAs can up-regulate translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
10	Loktionov A: Common gene polymorphisms, cancer progression and prognosis. Cancer Lett. 208:1–33. 2004. View Article : Google Scholar : PubMed/NCBI
11	Duan R, Pak C and Jin P: Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 16:1124–1131. 2007. View Article : Google Scholar : PubMed/NCBI
12	Zeng Y and Cullen BR: Sequence requirements for micro RNA processing and function in human cells. RNA. 9:112–123. 2003. View Article : Google Scholar : PubMed/NCBI
13	Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 69:5970–5977. 2009. View Article : Google Scholar : PubMed/NCBI
14	Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 118:2600–2608. 2008.PubMed/NCBI
15	Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie GZ, Sun AM and Liu Y: A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res. 42:144–148. 2011. View Article : Google Scholar : PubMed/NCBI
16	Schimanski CC: High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
17	Chen H, Sun LY, Chen LL, Zheng HQ and Zhang QF: A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J. 42:e115–e119. 2012. View Article : Google Scholar : PubMed/NCBI
18	Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I, Vyzula R and Slaby O: Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol. 18:2827–2831. 2012. View Article : Google Scholar : PubMed/NCBI
19	Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, Oh D and Kim NK: Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog. 51(Suppl 1): E65–E73. 2012.
20	Vinci S, Gelmini S, Mancini I, Malentacchi F, Pazzagli M, Beltrami C, Pinzani P and Orlando C: Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods. 59:138–146. 2013. View Article : Google Scholar : PubMed/NCBI
21	Zhu L, Chu H, Gu D, Ma L, Shi D, Zhong D, Tong N, Zhang Z and Wang M: A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol. 31:350–354. 2012. View Article : Google Scholar : PubMed/NCBI
22	Lau J, Ioannidis JP and Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med. 127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
23	Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
24	DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials. 7:177–188. 1986. View Article : Google Scholar : PubMed/NCBI
25	Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI
26	Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
27	Wang P, Xie S, Cui A, Zhang Y and Jiang B: miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects. Exp Ther Med. 3:324–330. 2012.PubMed/NCBI
28	Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, Liu ZH, Peng JY, Zhou YK and Qin HL: A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 39:269–275. 2012. View Article : Google Scholar : PubMed/NCBI
29	Chu H, Wang M, Shi D, Ma L and Zhang Z, Tong N, Huo X, Wang W, Luo D, Gao Y and Zhang Z: Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One. 6:e181082011. View Article : Google Scholar : PubMed/NCBI
30	Xu W, Xu J, Liu S, Chen B, Wang X, Li Y, Qian Y, Zhao W and Wu J: Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One. 6:e204712011. View Article : Google Scholar : PubMed/NCBI
31	Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, Wang JL, Wang BY, Lv FF, Wu XH and Hu LQ: miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine. 56:589–592. 2011. View Article : Google Scholar : PubMed/NCBI
32	Wang J, Wang Q, Liu H, Shao N, Tan B, Zhang G, Wang K, Jia Y, Ma W, Wang N and Cheng Y: The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 27:779–788. 2012. View Article : Google Scholar : PubMed/NCBI
33	Tian T, Xu Y, Dai J, Wu J, Shen H and Hu Z: Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet. 1:358–366. 2010.PubMed/NCBI
34	Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG and Zhang L: The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 125:571–574. 2011. View Article : Google Scholar : PubMed/NCBI
35	Wang Z, Cao Y, Jiang C, Yang G, Wu J and Ding Y: Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One. 7:e400392012. View Article : Google Scholar : PubMed/NCBI
36	Guo J, Jin M, Zhang M and Chen K: A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One. 7:e305852012. View Article : Google Scholar : PubMed/NCBI
37	Zambirinis CP, Theodoropoulos G and Gazouli M: Undefined familial colorectal cancer. World J Gastrointest Oncol. 1:12–20. 2009. View Article : Google Scholar
38	Burt R: Inheritance of colorectal cancer. Drug Discov Today Dis Mech. 4:293–300. 2007. View Article : Google Scholar
39	Patel SG and Ahnen DJ: Familial colon cancer syndromes: an update of a rapidly evolving field. Curr Gastroenterol Rep. 14:428–438. 2012. View Article : Google Scholar : PubMed/NCBI